Literature DB >> 12532453

Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus.

Ke Li1, Lin Wang, Jun Cheng, Yin-Ying Lu, Ling-Xin Zhang, Jin-Song Mu, Yuan Hong, Yan Liu, Hui-Juan Duan, Gang Wang, Li Li, Ju-Mei Chen.   

Abstract

AIM: To investigate the interaction between hepatitis C virus core protein and translin protein and its role in the pathogenensis of hepatocellular carcinoma and lymphoma.
METHODS: With the components of the yeast two hybrid system 3, "bait" plasmids of HCV core the gene was constructed. After proving that hepatitis C virus core protein could be firmly expressed in AH109 yeast strains, yeast two- hybrid screening was performed by mating AH109 with Y187 that transformed with liver cDNA library plasmids-pACT2 and then plated on quadruple dropout (QDO) medium and then assayed for alpha-gal activity. Sequencing analysis of the genes of library plasmids in yeast colonies that could grow on QDO with alpha-gal activity was performed. The interaction between HCV core protein and the protein we obtained from positive colony was further confirmed by repeating yeast two - hybrid analysis and coimmunoprecipitation in vitro.
RESULTS: A gene from a positive colony was the gene of translin, a recombination hotspot binding protein. The interaction between HCV core protein and translin protein could be proved not only in yeast, but also in vitro.
CONCLUSION: The core protein of HCV can interact with translin protein. This can partly explain the molecular mechanism for hepatocellular carcinoma and lymphoma caused by HCV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12532453      PMCID: PMC4611333          DOI: 10.3748/wjg.v9.i2.300

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

1.  Immunohistochemical detection of HCV infection in patients with hepatocellular carcinoma and other liver diseases.

Authors:  Li-Fa Zhang; Wen-Wei Peng; Ji-Lu Yao; Yong-Huang Tang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

2.  The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line.

Authors:  C S Hahn; Y G Cho; B S Kang; I M Lester; Y S Hahn
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

3.  T(14;18) translocation in chronic hepatitis C virus infection.

Authors:  A L Zignego; F Giannelli; M E Marrocchi; A Mazzocca; C Ferri; C Giannini; M Monti; P Caini; G L Villa; G Laffi; P Gentilini
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

4.  Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels.

Authors:  J W Cho; W K Baek; S I Suh; S H Yang; J Chang; Y C Sung; M H Suh
Journal:  Liver       Date:  2001-04

5.  bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection.

Authors:  E Zuckerman; T Zuckerman; D Sahar; S Streichman; D Attias; E Sabo; D Yeshurun; J Rowe
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

6.  Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates.

Authors:  A Sabile; G Perlemuter; F Bono; K Kohara; F Demaugre; M Kohara; Y Matsuura; T Miyamura; C Bréchot; G Barba
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

7.  Hepatitis C virus core protein binds to a DEAD box RNA helicase.

Authors:  N Mamiya; H J Worman
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

8.  Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma.

Authors:  P Pioltelli; L Gargantini; E Cassi; L Santoleri; G Bellati; E M Magliano; E Morra
Journal:  Am J Hematol       Date:  2000-06       Impact factor: 10.047

9.  Hepatitis C virus core protein interacts with cellular putative RNA helicase.

Authors:  L R You; C M Chen; T S Yeh; T Y Tsai; R T Mai; C H Lin; Y H Lee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

10.  Hepatocellular carcinoma and non-Hodgkin lymphoma in a patient with chronic hepatitis C and cirrhosis.

Authors:  A Suriawinata; M Q Ye; S Emre; J Strauchen; S N Thung
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

View more
  4 in total

1.  Screening and identification of interacting proteins with hepatitis B virus core protein in leukocytes and cloning of new gene C1.

Authors:  Shu-Mei Lin; Jun Cheng; Yin-Ying Lu; Shu-Lin Zhang; Qian Yang; Tian-Yan Chen; Min Liu; Lin Wang
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

2.  Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B.

Authors:  Dong Xu; De-Ying Tian; Zhen-Gang Zhang; Hong-Yun Chen; Pei-Hui Song
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  Sequence evolution of putative cytotoxic T cell epitopes in NS3 region of hepatitis C virus.

Authors:  Hua-Zhang Guo; Ying Yin; Wen-Liang Wang; Chuan-Shan Zhang; Tao Wang; Zhe Wang; Jing Zhang; Hong Cheng; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

Review 4.  Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Authors:  Youxi Yu; Xiaoju Shi; Xingtong Wang; Ping Zhang; Ou Bai; Yan Li
Journal:  Cell Biosci       Date:  2022-03-12       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.